» Articles » PMID: 24876185

Hospitalisation and Comorbidities in Parkinson's Disease: a Large Australian Retrospective Study

Overview
Date 2014 May 31
PMID 24876185
Citations 48
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Patients with Parkinson's disease (PD) require higher levels of care during hospitalisation. Management of comorbidities in these patients aims to optimise function while minimising complications. The objective of this study was to examine patterns of hospitalisation of patients with PD in NSW with regards to sociodemographic factors, comorbidities and aspects of clinical management.

Methods: A retrospective study of all patients with idiopathic PD and a control group of non-PD patients admitted for acute care to NSW hospitals between 2008 and 2012.

Results: The study group comprised 5637 cases and 8143 controls. The mean PD patient age was 75.0 years (±10.9). Patients with PD had a significantly longer hospital stay (median 7 days, IQR 3-13 vs 1 day, IQR 1-7, p<0.001) than control patients. Patients with PD were five times more likely to be treated for delirium, three times more likely to experience an adverse drug event and syncope, more than twice as likely to require management of falls/fractures, dementia, gastrointestinal complications, genitourinary infections, reduced mobility and other trauma but half as likely to require hospitalisation for chronic airways disease and neoplasia, including melanoma, than the control group (all p<0.001).

Conclusions: Patients with PD are more likely to suffer serious health problems, including delirium, adverse drug reactions, syncope, falls and fractures than controls. These findings highlight PD as a multisystem neuropsychiatric disorder in which motor and non-motor features contribute to morbidity. Increased awareness of the added risk PD poses in acute hospitalised patients can be used to inform strategies to improve patient outcomes.

Citing Articles

Using Healthcare Redesign to Identify Medication Management Issues in Parkinson's Disease.

Williams S, Iannuzzi M, Prior S Pharmacy (Basel). 2025; 13(1).

PMID: 39998011 PMC: 11859038. DOI: 10.3390/pharmacy13010013.


Characteristics, Complications, and Outcomes of Critical Illness in Patients with Parkinson Disease.

Lieberman O, Douglas V, LaHue S Neurocrit Care. 2024; 42(1):241-252.

PMID: 39112816 DOI: 10.1007/s12028-024-02062-7.


A review of the gastrointestinal, olfactory, and skin abnormalities in patients with Parkinson's disease.

Almikhlafi M Neurosciences (Riyadh). 2024; 29(1):4-9.

PMID: 38195133 PMC: 10827020. DOI: 10.17712/nsj.2024.1.20230062.


More than medications: a patient-centered assessment of Parkinson's disease care needs during hospitalization.

Shurer J, Golden S, Mihas P, Browner N Front Aging Neurosci. 2023; 15:1255428.

PMID: 37842122 PMC: 10569176. DOI: 10.3389/fnagi.2023.1255428.


The effects of medical comorbidity, cognition, and age on patient-reported outcomes in Parkinson's disease.

Kim H, Shulman L, Shakya S, Gruber-Baldini A Parkinsonism Relat Disord. 2023; 116:105892.

PMID: 37837675 PMC: 10841750. DOI: 10.1016/j.parkreldis.2023.105892.